AstraZeneca plc http://www.alacrastore.com/company-snapshot/AstraZeneca_plc-1069149 08 Nov 2009 08:05:19 EST 1069149 AstraZeneca plc en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/bir/519654519654bir/519654norm9AstraZeneca PLCAstra ABZeneca Group PLCMedImmune Inc.MedImmuneUS Bioscience Inc.Molecular Vacinations Inc.United Kingdom04 Nov 2009 06:22:32 ESTManufacturing: Manufactures pharmaceuticals related to cardiovascular, central nervous system, gastrointestinal, infection, oncology, and pain control.NYSE325412M2834IAZNManufacturing: Manufactures pharmaceuticals related to cardiovascular, central nervous system, gastrointestinal, infection, oncology, and pain control.Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/ccbn/T2502864T2502864ccbn/T2502864norm29 Oct 2009 02:09:35 EST2502864Final Transcript of AZN earnings conference call or presentation, 29-Oct-09 1:00pm UKTAstraZeneca PLC106.0000FinalAstraZeneca PLC Q3 2009 Earnings Conference Call TranscriptAZN1:00pm UKTTranscript...Sachin Jain BAS-ML - Analyst Kevin Wilson Citigroup - Analyst Tim Anderson Sanford C. Bernstein & Company, Inc. - Analyst Matthew Weston Credit Suisse - Analyst Andrew Baum Morgan Stanley - Analyst Gbola Amusa UBS - Analyst Lars Hevreng SEB Enskilda Inc. - Analyst Marcel Brand CA Cheuvreux - Analyst... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2502864B2502864ccbn/B2502864norm29 Oct 2009 02:09:33 EST2502864Edited Brief of AZN earnings conference call or presentation, 29-Oct-09 1:00pm UKTAstraZeneca PLC106.0000EditedAstraZeneca PLC Q3 2009 Earnings Conference Call SummaryAZN1:00pm UKTBrief...Sachin Jain BAS-ML - Analyst Kevin Wilson Citigroup - Analyst Tim Anderson Sanford C. Bernstein & Company, Inc. - Analyst Matthew Weston Credit Suisse - Analyst Andrew Baum Morgan Stanley - Analyst Gbola Amusa UBS - Analyst Lars Hevreng SEB Enskilda Inc. - Analyst Marcel Brand CA Cheuvreux - Analyst... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/research/fitch-ratings-Fitch_European_Pharma_Faces_Declining_Profitability_on_Diversification_Pressures-524736_pr_frame524736_pr_framefitch/524736_pr_framehtmlGlaxoSmithKline plcBayer AGSanofi-Aventis S.A.Smithkline Beecham CorporationRoche Holding Ltd.Novartis AGAstraZeneca plcGlaxosmithkline Finance Plc811087178045797681108707803624348258868380457972804579798588407329 Oct 2009 10:17:00 EST0103170085Press ReleaseGSKBAYNRONOVNSANAZNFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/newstex/BW-0001-39218342BW-0001-39218342newstex/BW-0001-39218342xmlNewstex Inc.2005POZEN Inc.Newstex Inc.newstex.comnewstexBW-0001-39218342Business Wire0001Business WireBW1Newstex Inc.Business Wire040000000401600004016001040160480401601804016003040020000400200607000000070140000701401228 Oct 2009 08:22:05 EST18000000180080001800400018020000190000001900100010/28/2009 Oct. ##, #### (Business Wire) -- POZEN Inc. (NASDAQ: POZN) , today announced results for the third quarter ended September ##, ####. Third Quarter Results POZEN reported a net income of $#.# million, or $#.## per share on a diluted...ASTRAZENECA PLCPOZEN INCElizabeth CermakAZNPOZNNewsNewstexhttp://www.alacrastore.com/research/fitch-ratings-AstraZeneca_PLC-474288_report_frame474288_report_framefitch/474288_report_framepdfAstraZeneca plc8036243416 Oct 2009 10:23:00 EST01031700425Full Rating ReportAZNFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/research/fitch-ratings-Fitch_Affirms_AstraZeneca_at_AA_Outlook_Stable-516936_pr_frame516936_pr_framefitch/516936_pr_framehtmlAstraZeneca plc8036243412 Oct 2009 10:11:00 EST0103170085Press ReleaseAZNFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/newstex/MW-0001-38638168MW-0001-38638168newstex/MW-0001-38638168xmlNewstex Inc.2005Copyright (c) 2009, Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited.RetroVirox Inc.SAN DIEGO, CANewstex Inc.newstex.comnewstexMW-0001-38638168Marketwire0001MarketwireMW1Newstex Inc.Marketwire09000000090150000400000004002000040020060401600004016008070000000701400007014012070030000700300113000000130100001301000508 Oct 2009 08:22:49 EST180000001800700019000000190010001900100510/8/2009 SAN DIEGO, CA, Oct. #, #### (Marketwire delivered by Newstex) -- SAN DIEGO, CA -- (Marketwire) -- ##/##/## -- RetroVirox, Inc., a biotechnology company focused on developing novel antivirals, announced today the appointment of Ronald...ASTRAZENECA PLCGLAXOSMITHKLINE PLCNOVARTIS AGAZNGSKNVSNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MCOM-0004-38346395MCOM-0004-38346395newstex/MCOM-0004-38346395xmlNewstex Inc.2005Copyright (c) M2 Communications Ltd.Newstex Inc.newstex.comnewstexMCOM-0004-38346395M2 EquityBites0004M2 Communications Ltd.MCOM1Newstex Inc.M2040000000400200004002006040160000401603102000000020020000200200807000000070140000701401228 Sep 2009 01:33:10 EST18000000180180009/28/2009 Sep. ##, #### (M# Communications Ltd. delivered by Newstex) -- ## September #### - Anglo-Swedish pharma major AstraZeneca (LON: AZN) (STO: AZN) said last Friday that it has won an appeal against generic drug makers Teva Pharmaceutical...ASTRAZENECA PLCNOVARTIS AGTEVA PHARMACEUTICAL INDUSTRIES LTDAZNNVSTEVANewsNewstexhttp://www.alacrastore.com/storecontent/fitch/511836_pr_frame511836_pr_framefitch/511836_pr_framehtmlAbbott LaboratoriesAkzo Nobel N.V.AstraZeneca plcBASF SEBayer AGL'Oreal SAMerck & Company, Inc.Novartis AGSanofi-Aventis S.A.Solvay SA8036051580360517803605948036137280361592803624348045797680457979837464658588407328 Sep 2009 10:12:00 EST01030200010311000103170085Press ReleaseABTAKZAAZNBASBAYNMRKNOVNORSANSOLBFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/newstex/MW-0001-38331525MW-0001-38331525newstex/MW-0001-38331525xmlNewstex Inc.2005Copyright (c) 2009, Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited.UCBBRUSSELS, BELGIUMNewstex Inc.newstex.comnewstexMW-0001-38331525Marketwire0001MarketwireMW1Newstex Inc.Marketwire040000000400200004002006040160000401601307000000070140000701400628 Sep 2009 02:30:23 EST1800000018022000180150001900000019002000190020071900201019002015190020189/28/2009 BRUSSELS, BELGIUM, Sep. ##, #### (Marketwire delivered by Newstex) -- BRUSSELS, BELGIUM -- (Marketwire) -- ##/##/## -- UCB and AstraZeneca announced today that they have entered into a partnership to register and commercialize UCB's...ASTRAZENECA PLCUCBAZNUCBUCBJYNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38291613BW-0001-38291613newstex/BW-0001-38291613xmlNewstex Inc.2005Teva Pharmaceutical Industries Ltd.Newstex Inc.newstex.comnewstexBW-0001-38291613Business Wire0001Business WireBW1Newstex Inc.Business Wire040000000400200004002006070000000701400007014012070030000700300113000000130100001301000502000000020020000200200425 Sep 2009 05:22:35 EST1800000018020000180180001900000019001000190020049/25/2009 Sep. ##, #### (Business Wire) -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a July #, #### decision by the District Court to grant AstraZenecaÂ’s...ASTRAZENECA PLCTEVA PHARMACEUTICAL INDUSTRIES LTDAZNTEVANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38125583BW-0001-38125583newstex/BW-0001-38125583xmlNewstex Inc.2005ReportLinkerNewstex Inc.newstex.comnewstexBW-0001-38125583Business Wire0001Business WireBW1Newstex Inc.Business Wire04000000040180000700000007014000070140120700300007003001040020000400200604016000040160050400600004006005130000001301000013010005130010001300100202000000020020000200200621 Sep 2009 10:39:23 EST180000001802000018002000180160009/21/2009 Sep. ##, #### (Business Wire) -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds AstraZeneca plc: PharmaVitae Profile http://www.reportlinker.com/p#######/Reportlinker-Adds-AstraZeneca-plc-Pha...ASTRAZENECA PLCAZNNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38084405BW-0001-38084405newstex/BW-0001-38084405xmlNewstex Inc.2005Zacks.comNewstex Inc.newstex.comnewstexBW-0001-38084405Business Wire0001Business WireBW1Newstex Inc.Business Wire040000000400300004003004040160000401600513000000130100001301000307000000070030000700300118 Sep 2009 06:21:22 EST180000001801600018022000190020079/18/2009 Sep. ##, #### (Business Wire) -- Zacks Equity Research highlights ON Semiconductor (Nasdaq: ONNN ) as the Bull of the Day and Developers Diversified (NYSE: DDR ) the Bear of the Day. In addition, Zacks Equity Research provides analysis...ALCON INCALLERGAN INCASTRAZENECA PLCON SEMICONDUCTOR CORPACLAGNAZNONNNNewsNewstexhttp://www.alacrastore.com/storecontent/fitch/465450_report_frame465450_report_framefitch/465450_report_framepdfEli Lilly & CompanySanofi-Aventis S.A.Glaxosmithkline Finance PlcWyethPfizer Inc.Merck & Company, Inc.Roche Holding Ltd.Bristol-Myers Squibb CompanyAbbott LaboratoriesJohnson & JohnsonAstraZeneca plcBayer AGNovartis AGSchering-Plough CorporationAmgen, Inc.85884073803616308045797680656236803615928084388480361372803624348071041080361419811087078009174082588683850944738045797910 Sep 2009 02:17:00 EST01031700275Special ReportJNJWYESANBMYAMGNABTROBAYNMRKPFELLYSGPAZNNOVNFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/newstex/BW-0001-37495474BW-0001-37495474newstex/BW-0001-37495474xmlNewstex Inc.2005Dyax Corp.Newstex Inc.newstex.comnewstexBW-0001-37495474Business Wire0001Business WireBW1Newstex Inc.Business Wire0700000007005000130000001300700007003000070030010701400007014012070140080700100007001004040000000400200004002006130100001301000526 Aug 2009 08:28:16 EST18000000180220008/26/2009 Aug. ##, #### (Business Wire) -- Dyax Corp. (NASDAQ:DYAX) announced today successful advancement into Phase # clinical trials of two candidates identified using DyaxÂ’s proprietary phage display technology by licensees of the CompanyÂ’s...ASTRAZENECA PLCDYAX CORPLILLY ELI & COGustav ChristensenAZNDYAXLLYNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B2330462B2330462ccbn/B2330462norm30 Jul 2009 07:07:00 EST2330462Edited Brief of AZN earnings conference call or presentation, 30-Jul-09 1:00pm UKTAstraZeneca PLC54.0000EditedH1 2009 AstraZeneca PLC Earnings Conference Call SummaryAZN1:00pm UKTBrief...Jonathan Hunt AstraZeneca Plc - IR Officer David Brennan AstraZeneca Plc - CEO Simon Lowth AstraZeneca Plc - CFO Anders Ekblom AstraZeneca Plc - EVP, Development CONFERENCE CALL PARTICIPANTS... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2330462T2330462ccbn/T2330462norm30 Jul 2009 02:09:00 EST2330462Final Transcript of AZN earnings conference call or presentation, 30-Jul-09 1:00pm UKTAstraZeneca PLC54.0000FinalH1 2009 AstraZeneca PLC Earnings Conference Call TranscriptAZN1:00pm UKTTranscript...Jonathan Hunt AstraZeneca Plc - IR Officer David Brennan AstraZeneca Plc - CEO Simon Lowth AstraZeneca Plc - CFO Anders Ekblom AstraZeneca Plc - EVP, Development C O N F E R E N C E C A L L P A R T I C I P A N T S... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/moodys/PBC_118537PBC_118537moodys/PBC_118537pdf10 Jul 2009 12:45:35 ESTpdfAstraZeneca PLCAstraZeneca PLC600011131300.000009 Jul 2009AnalysisAnalysisC...Headquartered in the UK, AstraZeneca plc (rated A#/stable) was formed in April #### through the merger of Astra AB of Sweden and Zeneca Group plc of the UK. AstraZeneca is a strong global pharmaceutical company, which after recent merger-activity in the industry, is ranking eighth worldwide in total revenues and spanning six major therapeutic areas: gastrointestinal; neuroscience; oncology; cardiovascular; respiratory; and infection and inflammation. The company completed the acquisition of the biotechnology company MedImmune in June ####. Figure #: More than ##% of Revenues Came from Gastrointestinal and Cardiovascular Therapeutic Areas in ####... Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/research/s-and-p-credit-research-Summary_AstraZeneca_PLC-732500732500spcred/732500normglobal08 Jul 2009 01:10:00 EST175SummaryThe latest Summary from S&PUnited KingdomEurope, Middle East, AfricaGlobal IssuersSummaryGBR04635304635P04635R35202010 352020 3520 35AstraZeneca PLC126474EUROMIDAFRUSAAZN@LNSUMMARYConsumerCORPGLOBISSHealthUnited StatesPharmaceuticalsCredit & Investment ResearchS&P Credit Research